16th week of 2021 patent applcation highlights part 24 |
Patent application number | Title | Published |
20210115002 | PRODRUG COMPOUNDS ACTIVATED BY AKR1C3 AND THEIR USE FOR TREATING HYPERPROLIFERATIVE DISORDERS | 2021-04-22 |
20210115003 | NOVEL FULLY SYNTHETIC AND SEMISYNTHETIC PLEUROMUTILIN DERIVATIVES AS NEW ANTIBIOTICS AND THEIR PREPARATION | 2021-04-22 |
20210115004 | A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF | 2021-04-22 |
20210115005 | DIELS-ALDER RING-OPENING PROCESS | 2021-04-22 |
20210115006 | NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT | 2021-04-22 |
20210115007 | STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY | 2021-04-22 |
20210115008 | P300/CBP HAT INHIBITORS | 2021-04-22 |
20210115009 | METHOD FOR SYNTHESIS OF DEUTERATED AMIDE AND DEUTERATED SULFONAMIDE | 2021-04-22 |
20210115010 | BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE | 2021-04-22 |
20210115011 | NOVEL PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF CANNABINOID RECEPTOR 2 | 2021-04-22 |
20210115012 | RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND | 2021-04-22 |
20210115013 | TLR7/8 ANTAGONISTS AND USES THEREOF | 2021-04-22 |
20210115014 | COMPOUND, COMPOSITION, AND USE THEREOF IN PREPARATION OF DRUG | 2021-04-22 |
20210115015 | N-(4-PYRIDYL)NICOTINAMIDE COMPOUND OR SALT THEREOF | 2021-04-22 |
20210115016 | AMIDO COMPOUNDS AS AhR MODULATORS | 2021-04-22 |
20210115017 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | 2021-04-22 |
20210115018 | PIPERIDINE COMPOUNDS AS COVALENT MENIN INHIBITORS | 2021-04-22 |
20210115019 | SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-Y- L)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND SALTS THEREOF, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2021-04-22 |
20210115020 | ASK1 INHIBITING AGENTS | 2021-04-22 |
20210115021 | ADHESIVE COMPOSITION FOR SEMICONDUCTOR CIRCUIT CONNECTION AND ADHESIVE FILM CONTAINING THE SAME | 2021-04-22 |
20210115022 | THYROID HORMONE RECEPTOR AGONISTS AND USES THEREOF | 2021-04-22 |
20210115023 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | 2021-04-22 |
20210115024 | Small molecule inducers of autophagy | 2021-04-22 |
20210115025 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2021-04-22 |
20210115026 | NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2021-04-22 |
20210115027 | PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS | 2021-04-22 |
20210115028 | PLASTICIZER COMPOSITION AND RESIN COMPOSITION INCLUDING THE SAME | 2021-04-22 |
20210115029 | PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS | 2021-04-22 |
20210115030 | DIHYDRATE OF BENZOTHIOPHENE COMPOUND OR OF A SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME | 2021-04-22 |
20210115031 | BENZOFURANE AND BENZOTHIOPHENE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | 2021-04-22 |
20210115032 | PROCESSES FOR THE PREPARATION OF FURAZANOBENZIMIDAZOLES AND CRYSTALLINE FORMS THEREOF | 2021-04-22 |
20210115033 | CRYSTALLINE FORMS OF THE CXCR7 RECEPTOR ANTAGONIST (3S,4S)-1-CYCLOPROPYLMETHYL-4-{[5-(2,4-DIFLUORO-PHENYL)-ISOXAZOLE-3-CARBO- NYL]-AMINO}-PIPERIDINE-3-CARBOXYLIC ACID (1-PYRIMIDIN-2-YL-CYCLOPROPYL)-AMIDE | 2021-04-22 |
20210115034 | AMIDE COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | 2021-04-22 |
20210115035 | MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION | 2021-04-22 |
20210115036 | AZAINDOLES AND METHODS OF USE THEREOF | 2021-04-22 |
20210115037 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS | 2021-04-22 |
20210115038 | MALIC ENZYME INHIBITORS | 2021-04-22 |
20210115039 | COCRYSTAL | 2021-04-22 |
20210115040 | OGA INHIBITOR COMPOUNDS | 2021-04-22 |
20210115041 | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS | 2021-04-22 |
20210115042 | ERGOLINE COMPOUNDS AND USES THEREOF | 2021-04-22 |
20210115043 | Process for Extracting and Purifying Rauwolscine from Rouwolfia Plant | 2021-04-22 |
20210115044 | TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | 2021-04-22 |
20210115045 | HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER | 2021-04-22 |
20210115046 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | 2021-04-22 |
20210115047 | CDPK1 INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO | 2021-04-22 |
20210115048 | HETEROCYCLIC COMPOUND | 2021-04-22 |
20210115049 | SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | 2021-04-22 |
20210115050 | CRYSTALLINE FORMS OF AN sGC STIMULATOR | 2021-04-22 |
20210115051 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | 2021-04-22 |
20210115052 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-04-22 |
20210115053 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | 2021-04-22 |
20210115054 | TRIAZOLO[4,5-D] PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS | 2021-04-22 |
20210115055 | LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | 2021-04-22 |
20210115056 | Pharmaceutical Intermediates and Methods for Preparing the Same | 2021-04-22 |
20210115057 | PROTEASOME ACTIVITY ENHANCING COMPOUNDS | 2021-04-22 |
20210115058 | SPIROCYCLIC COMPOUNDS | 2021-04-22 |
20210115059 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | 2021-04-22 |
20210115060 | FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS | 2021-04-22 |
20210115061 | Small-Molecule HIV-1 Capsid Protein Inhibitors and Methods Using Same | 2021-04-22 |
20210115063 | MUTANT KRAS INHIBITORS | 2021-04-22 |
20210115064 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2021-04-22 |
20210115065 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | 2021-04-22 |
20210115066 | DITHIO ETP DERIVATIVES | 2021-04-22 |
20210115067 | FUSED HETEROCYCLIC COMPOUND | 2021-04-22 |
20210115068 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2021-04-22 |
20210115069 | ORGANIC LUMINESCENT MATERIAL HAVING AN ANCILLARY LIGAND WITH A PARTIALLY FLUORINE-SUBSTITUTED SUBSTITUENT | 2021-04-22 |
20210115071 | NANOSCALE METAL-ORGANIC FRAMEWORKS FOR ENHANCED TUMOR CHEMORADIATION | 2021-04-22 |
20210115072 | Luminescent Metal Halide Perovskites and Methods | 2021-04-22 |
20210115073 | Preparation Method Of Solid Catalyst For Propylene Polymerization | 2021-04-22 |
20210115074 | PHOSPHONAMIDATE BUTYROPHILIN LIGANDS | 2021-04-22 |
20210115075 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | 2021-04-22 |
20210115076 | THERMOELECTRIC CONVERSION ELEMENT | 2021-04-22 |
20210115077 | Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound | 2021-04-22 |
20210115078 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | 2021-04-22 |
20210115079 | CHIRAL PLATINUM COMPLEX, METHOD FOR PREPARING THE SAME, AND METHOD FOR USING THE SAME | 2021-04-22 |
20210115080 | DIHYDROCARBYL-SILYL-BRIDGED-1,3 DISUBSTITUTED-2-INDENYL METALLOCENE COMPLEXES FOR OLEFIN POLYMERIZATION | 2021-04-22 |
20210115081 | PROCESS FOR PREPARING CONCENTRATED SOLUTIONS OF STEVIOL GLYCOSIDES, AND USES | 2021-04-22 |
20210115082 | GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE | 2021-04-22 |
20210115083 | RNA NANOPARTICLES FOR BRAIN TUMOR TREATMENT | 2021-04-22 |
20210115084 | INDUSTRIAL PROCESS FOR THE SYNTHESIS OF NOMEGESTROL-ACETATE | 2021-04-22 |
20210115085 | CONTINUOUS, SOLVENT-FREE AND NON-ENZYMATIC PEPTIDE SYNTHESIS BY REACTIVE EXTRUSION | 2021-04-22 |
20210115086 | PEPTIDE FOR IMPROVING MEMORY AND PREVENTING OR ALLEVIATING COGNITIVE DYSFUNCTION, COMPOSITION COMPRISING THE SAME, AND METHOD FOR PRODUCING THE SAME | 2021-04-22 |
20210115087 | CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS | 2021-04-22 |
20210115088 | BICYCLIC PEPTIDYL INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA | 2021-04-22 |
20210115089 | ANTITUMOR PEPTIDE AND USE THEREOF | 2021-04-22 |
20210115090 | DE NOVO DESIGN OF PROTEIN SWITCHES | 2021-04-22 |
20210115091 | METHODS AND COMPOSITIONS FOR DUAL GLYCAN BINDING AAV VECTORS | 2021-04-22 |
20210115092 | SYSTEMS AND METHODS FOR INCREASING EFFICIENCY OF GENOME EDITING | 2021-04-22 |
20210115093 | ANIMAL PATHOGEN-DERIVED POLYPEPTIDES AND USES THEREOF FOR GENETIC ENGINEERING | 2021-04-22 |
20210115094 | TARGET RECOGNITION MOTIFS AND USES THEREOF | 2021-04-22 |
20210115095 | GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) | 2021-04-22 |
20210115096 | COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE | 2021-04-22 |
20210115097 | IGE EPITOPE-LIKE PEPTIDES AND USES THEREOF | 2021-04-22 |
20210115098 | AGENT AND METHOD FOR ENHANCING FERTILITY | 2021-04-22 |
20210115099 | PEPTIDES | 2021-04-22 |
20210115100 | VARIANTS OF HUMAN BMP7 PROTEIN | 2021-04-22 |
20210115101 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE | 2021-04-22 |
20210115102 | SEPARATION MOIETIES AND METHODS OF USE THEREOF | 2021-04-22 |
20210115103 | LONG-ACTING ADRENOMEDULLIN DERIVATIVE | 2021-04-22 |